{"id":1433,"date":"2021-09-16T18:11:00","date_gmt":"2021-09-16T18:11:00","guid":{"rendered":"https:\/\/navyblue.bcmultistaging.wpenginepowered.com\/?p=1433"},"modified":"2026-05-15T17:31:05","modified_gmt":"2026-05-15T17:31:05","slug":"research-roundup-september-2021","status":"publish","type":"post","link":"https:\/\/www.bcchr.ca\/levingslab\/2021\/09\/16\/research-roundup-september-2021\/","title":{"rendered":"Research Roundup: September 2021"},"content":{"rendered":"<p class=\"fndry-paragraph fndry-text-intro22\"><em>Welcome to this month&#8217;s Research Roundup, a recurring overview of recent studies published by researchers at BC Children&#8217;s Hospital Research Institute (BCCHR) and the University of British Columbia, and their collaborators.<\/em><\/p>\n\n<figure  class=\"fndry-image fndry-mb--2 fndry-mr--auto fndry-ml--auto\" style=\"--imageWidth:50%\" aria-labelledby=\"img-2416\">\n\t<img loading=\"lazy\" decoding=\"async\" width=\"600\" height=\"600\" src=\"https:\/\/www.bcchr.ca\/levingslab\/files\/2025\/01\/research-roundup-september-16-2021.jpg\" class=\"fndry-image__img\" aria-hidden=\"true\" role=\"presentation\" style=\"--borderRadius:0px;--objectFit:cover;--imagePosX:50%;--imagePosY:50%\" srcset=\"https:\/\/www.bcchr.ca\/levingslab\/files\/2025\/01\/research-roundup-september-16-2021.jpg 600w, https:\/\/www.bcchr.ca\/levingslab\/files\/2025\/01\/research-roundup-september-16-2021-300x300.jpg 300w, https:\/\/www.bcchr.ca\/levingslab\/files\/2025\/01\/research-roundup-september-16-2021-150x150.jpg 150w\" sizes=\"(max-width: 600px) 100vw, 600px\" \/><\/figure>\n\n\n<h3 class=\"fndry-heading\">Medicinal cannabis could reduce behavioural difficulties in autistic children<\/h3>\n\n<p class=\"fndry-paragraph\"><strong>BCCHR theme<\/strong>:\u00a0<a href=\"https:\/\/www.bcchr.ca\/research\/research-themes\/brain-behaviour-development\/\" target=\"_blank\" rel=\"noreferrer noopener\">Brain, Behaviour &#038; Development<\/a><\/p>\n\n<p class=\"fndry-paragraph\">Autism is a neurodevelopmental condition diagnosed in one in 66 children in Canada. Some autistic children experience behavioural difficulties such as self-injury and aggression, yet parents report a lack of effective, long-term treatment options. Medicinal cannabis has emerged in recent years as a promising option for helping to improve some autism-related behaviours.\u00a0<a href=\"https:\/\/www.bcchr.ca\/research\/find-a-researcher\/hal-siden\/\" target=\"_blank\" rel=\"noreferrer noopener\">Dr. Harold Siden<\/a>, Sarah Fletcher, Colleen Pawliuk, Dr. Angie Ip, Dr. Linda Huh,\u00a0<a href=\"https:\/\/www.bcchr.ca\/research\/find-a-researcher\/rod-rassekh\/\" target=\"_blank\" rel=\"noreferrer noopener\">Dr. Rod Rassekh<\/a>\u00a0and\u00a0<a href=\"https:\/\/www.bcchr.ca\/research\/find-a-researcher\/tim-oberlander\/\" target=\"_blank\" rel=\"noreferrer noopener\">Dr. Tim Oberlander<\/a>\u00a0conducted a scoping review of eight studies that looked at the use of medicinal cannabis formulations in autistic children and adolescents. Symptoms commonly reported as improved during treatment included anxiety, behavioural challenges, cognitive deficits, hyperactivity, mood, self-injury and sleep disturbance. Some of the studies reported that participants were able to reduce their other medications (e.g., benzodiazepines) while taking medicinal cannabis; and six of the eight studies reported mild adverse events such as sleepiness, changes in appetite and restlessness.<\/p>\n\n<p class=\"fndry-paragraph\">\u201cThese studies were characterized by variations in study designs (observational studies, retrospective reviews and case studies), sample sizes, outcome measures, duration of treatment and nature of side effects. All studies reported improvement in autism-related behavioural symptoms after starting on medicinal cannabis treatment,\u201d wrote Dr. Siden and his team in \u201cMedicinal Cannabis in Children and Adolescents With Autism Spectrum Disorder: A Scoping Review.\u201d The researchers caution that stronger evidence of medicinal cannabis\u2019s efficacy in reducing autism-related symptoms is needed.<\/p>\n\n<p class=\"fndry-paragraph\">Read more in&nbsp;<a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cch.12909\" target=\"_blank\" rel=\"noreferrer noopener\"><em>Child: Care, Health and Development<\/em><\/a>.<\/p>\n\n<h3 class=\"fndry-heading\">Using CRISPR to fine-tune new treatment for transplant rejection<\/h3>\n\n<p class=\"fndry-paragraph\"><strong>BCCHR theme<\/strong>:\u00a0<a href=\"https:\/\/www.bcchr.ca\/research\/research-themes\/childhood-diseases\/\" target=\"_blank\" rel=\"noreferrer noopener\">Childhood Diseases<\/a><\/p>\n\n<p class=\"fndry-paragraph\">Transplant rejection occurs when an organ recipient\u2019s immune system attacks the donated organ. Current treatment involves the use of immunosuppressive drugs, but this can leave patients vulnerable to other diseases such as infections or cancer.\u00a0<a href=\"https:\/\/www.bcchr.ca\/research\/find-a-researcher\/megan-levings\/\" target=\"_blank\" rel=\"noreferrer noopener\">Dr. Megan Levings<\/a>, Dr. Avery Lam and Jana Gillies, with assistance from\u00a0<a href=\"https:\/\/www.bcchr.ca\/research\/find-a-researcher\/michael-steffen-kobor\/\" target=\"_blank\" rel=\"noreferrer noopener\">Dr. Michael Kobor<\/a>, Dr. David Lin and additional collaborators, have developed a new approach to this problem by engineering a type of immune cell known as a regulatory T cell (Treg) to be used as a cell therapy. This treatment strategy works by dampening the immune response to a specific target, like a donated organ, while leaving the immune system fully capable of dealing with other threats. To perfect this type of treatment, the team interrogated the underlying biology of these cells. In a new paper titled \u201cOptimized CRISPR-Mediated Gene Knock-In Reveals FOXP3-Independent Maintenance of Human Treg Identity,\u201d the team optimized a method of generating these Tregs using CRISPR to successfully switch in or out genes of interest. As part of the study, they eliminated FOXP3, a key component of Tregs, and surprisingly found that this had little impact on the overall function of the cells. Neither DNA methylation, mRNA or protein expression were largely affected, suggesting that although FOXP3 is crucial for Treg development, it may not be needed once these cells have matured.<\/p>\n\n<p class=\"fndry-paragraph\">\u201cOur goal is to move forward from unmodified Tregs to a more tailored therapy that is specific to a child\u2019s condition,\u201d said Avery Lam. \u201cThe next steps are to use these techniques to investigate other genes to further refine this cellular therapy.\u201d<\/p>\n\n<p class=\"fndry-paragraph\">Read more in&nbsp;<a href=\"https:\/\/www.cell.com\/cell-reports\/fulltext\/S2211-1247(21)00921-9\" target=\"_blank\" rel=\"noreferrer noopener\"><em>Cell Reports<\/em><\/a>.<\/p>\n\n<h3 class=\"fndry-heading\">An adolescent\u2019s gender plays important role in shaping food choices during transition to secondary school<\/h3>\n\n<p class=\"fndry-paragraph\"><strong>BCCHR theme<\/strong>:\u00a0<a href=\"https:\/\/www.bcchr.ca\/research\/research-themes\/evidence-to-innovation\/\">Evidence to Innovation<\/a><\/p>\n\n<p class=\"fndry-paragraph\">The transition between elementary school and secondary school is typically marked by a decline in eating habits, such as eating less fruits and vegetables, consuming more sugary foods and beverages, and skipping meals.\u00a0<a href=\"https:\/\/www.bcchr.ca\/research\/find-a-researcher\/louise-c-masse\/\" target=\"_blank\" rel=\"noreferrer noopener\">Dr. Louise M\u00e2sse<\/a>, Alysha Deslippe and their collaborators found that this decline in eating habits is impacted by different societal expectations placed on boys and girls. For example, girls are typically influenced by the pressure to be thin while boys are influenced by the pressure to gain muscle mass. Policy guidelines in Canada have called for more multi-level interventions that focus on the effects of different environments and social influences on dietary behaviours in adolescence. The researchers\u2019 findings, however, highlight the need to consider different gender-specific patterns of behaviour that may complicate one-size-fits-all interventions designed to target this age group. These gender-based differences should help inform the development of future interventions.<\/p>\n\n<p class=\"fndry-paragraph\">\u201cWe found that boys\u2019 and girls\u2019 dietary behaviours became increasingly differentiated along gendered lines following the transition [from elementary to secondary school]. \u2026 As schools have been suggested as a highly feasible and efficacious environment in promoting healthy eating among adolescents, future programs within schools should consider gender differences in how boys and girls interact with food,\u201d wrote Dr. M\u00e2sse, Alysha Deslippe and their team in \u201cGender Plays a Role in Adolescents\u2019 Dietary Behaviors as They Transition to Secondary School.\u201d<\/p>\n\n<p class=\"fndry-paragraph\">Read more in&nbsp;<a href=\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0195666321005493\" target=\"_blank\" rel=\"noreferrer noopener\"><em>Appetite<\/em><\/a>.<\/p>\n\n<h3 class=\"fndry-heading\">Early-life cytomegalovirus infection increases risk of childhood allergies<\/h3>\n\n<p class=\"fndry-paragraph\"><strong>BCCHR theme<\/strong>:\u00a0<a href=\"https:\/\/www.bcchr.ca\/research\/research-themes\/healthy-starts\/\" target=\"_blank\" rel=\"noreferrer noopener\">Healthy Starts<\/a><\/p>\n\n<p class=\"fndry-paragraph\">Cytomegalovirus (CMV) is a common virus that impacts populations around the world. While CMV infection is often asymptomatic, it can lead to severe disease outcomes and long-term consequences in some individuals \u2014 especially those who are immunocompromised. In Canada, CMV prevalence in children aged 1-2 is under 20 per cent, but prevalence increases with age. Roughly 60 per cent of adults in highly developed countries are infected with CMV by 50 years of age.\u00a0Dr. Soren Gantt,\u00a0<a href=\"https:\/\/www.bcchr.ca\/research\/find-a-researcher\/stuart-turvey\/\" target=\"_blank\" rel=\"noreferrer noopener\">Dr. Stuart Turvey<\/a>, Dr. Hind Sbihi, Karen Simmons, Darlene Dai, Dr. Brett Finlay and their collaborators found that CMV infection during early life can lead to significant disruption in the balance of intestinal microbiota. Their research is the first of its kind to provide evidence that early-life CMV infection affects the diversity and number of bacteria in the gut. Their findings also provide evidence that elimination of CMV through vaccination is not likely to contribute to the development of allergies.<\/p>\n\n<p class=\"fndry-paragraph\">\u201cOur work indicates that preventing CMV infection would not put children at increased risk of developing atopy [allergic diseases]. Rather, a CMV vaccine, in addition to preventing CMV-associated morbidity and mortality, might reduce the risk of childhood allergic diseases,\u201d wrote Dr. Gantt and his team in \u201cEarly-Life Cytomegalovirus Infection Is Associated With Gut Microbiota Perturbations and Increased Risk of Atopy.\u201d<\/p>\n\n<p class=\"fndry-paragraph\">Read more in&nbsp;<a href=\"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/pai.13658\" target=\"_blank\" rel=\"noreferrer noopener\"><em>Pediatric Allergy and Immunology<\/em><\/a>.<\/p>","protected":false},"excerpt":{"rendered":"<p>Welcome to this month&#8217;s Research Roundup, a recurring overview of recent studies published by researchers at BC Children&#8217;s Hospital Research Institute (BCCHR) and the University of British Columbia, and their collaborators.<\/p>\n","protected":false},"author":2,"featured_media":2418,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_lmt_disableupdate":"no","_lmt_disable":"","inline_featured_image":false,"footnotes":"","fndry_alternate_title":""},"categories":[10],"tags":[19,18,20,21,23,12],"class_list":["post-1433","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-allergies","tag-autism","tag-diet","tag-eating-habits","tag-regulatory-t-cells","tag-tregs"],"modified_by":"Andrea Sakamoto","_links":{"self":[{"href":"https:\/\/www.bcchr.ca\/levingslab\/wp-json\/wp\/v2\/posts\/1433","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.bcchr.ca\/levingslab\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.bcchr.ca\/levingslab\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.bcchr.ca\/levingslab\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.bcchr.ca\/levingslab\/wp-json\/wp\/v2\/comments?post=1433"}],"version-history":[{"count":2,"href":"https:\/\/www.bcchr.ca\/levingslab\/wp-json\/wp\/v2\/posts\/1433\/revisions"}],"predecessor-version":[{"id":2420,"href":"https:\/\/www.bcchr.ca\/levingslab\/wp-json\/wp\/v2\/posts\/1433\/revisions\/2420"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.bcchr.ca\/levingslab\/wp-json\/wp\/v2\/media\/2418"}],"wp:attachment":[{"href":"https:\/\/www.bcchr.ca\/levingslab\/wp-json\/wp\/v2\/media?parent=1433"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.bcchr.ca\/levingslab\/wp-json\/wp\/v2\/categories?post=1433"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.bcchr.ca\/levingslab\/wp-json\/wp\/v2\/tags?post=1433"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}